Jenny Swalec has over 25 years of regulatory affairs experience. Previously, she was vice president of regulatory affairs at Castle Creek Pharmaceuticals, a Paragon portfolio company. Ms. Swalec served in the same role at Marathon Pharmaceuticals and as senior director of global regulatory affairs at Lundbeck. She has played a pivotal role in multiple new drug applications in the U.S. that received first cycle approvals, as well as numerous global clinical trial applications. She began her career as manager of regulatory affairs at Parke Davis. Ms. Swalec earned a bachelor’s degree in biology and chemistry from Eastern Michigan University.